Animal models of hereditary diffuse gastric cancer and lobular breast cancer provide additional support for this concept, whereby CDH1 germline deficiency in combination with a second hit (carcinogen treatment or TP53 mutation) is sufficient to initiate disease development [42,43]. Here, CDH1 is linked to Hereditary breast cancer.